COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.Biofactors. 2020 May; 46(3):306-308.B
Links
MeSH
Angiotensin-Converting Enzyme 2Antiviral AgentsBetacoronavirusCOVID-19Coronavirus InfectionsCytokine Release SyndromeHumansLungLuteolinMast CellsPandemicsPeptidyl-Dipeptidase APneumonia, ViralQuercetinRenin-Angiotensin SystemResearch DesignRespiratory System AgentsSARS-CoV-2Severity of Illness IndexSpike Glycoprotein, Coronavirus
Pub Type(s)
Editorial
Language
eng
PubMed ID
32339387
Citation
Theoharides, Theoharis C.. "COVID-19, Pulmonary Mast Cells, Cytokine Storms, and Beneficial Actions of Luteolin." BioFactors (Oxford, England), vol. 46, no. 3, 2020, pp. 306-308.
Theoharides TC. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 2020;46(3):306-308.
Theoharides, T. C. (2020). COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. BioFactors (Oxford, England), 46(3), 306-308. https://doi.org/10.1002/biof.1633
Theoharides TC. COVID-19, Pulmonary Mast Cells, Cytokine Storms, and Beneficial Actions of Luteolin. Biofactors. 2020;46(3):306-308. PubMed PMID: 32339387.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
A1 - Theoharides,Theoharis C,
Y1 - 2020/04/27/
PY - 2020/4/6/received
PY - 2020/4/7/accepted
PY - 2020/4/28/pubmed
PY - 2020/7/2/medline
PY - 2020/4/28/entrez
SP - 306
EP - 308
JF - BioFactors (Oxford, England)
JO - Biofactors
VL - 46
IS - 3
SN - 1872-8081
UR - https://www.unboundmedicine.com/medline/citation/32339387/COVID_19_pulmonary_mast_cells_cytokine_storms_and_beneficial_actions_of_luteolin_
DB - PRIME
DP - Unbound Medicine
ER -